Prof. Dr. Jan Tytgat, Design and biological evaluation of potassium ion channels inhibitors, KU Leuven, Belgium; https://www.kuleuven.be/wieiswie/en/person/00018354
Prof. Dr. Luis Pardo, The role of voltage-gated potassium ion channels inhibits in cancer, the study of ion channels, the molecular mechanisms underlying their function, and of the impact this has on the behavior of cells, both in physiological and in pathological conditions; Max Planck Institute for Multidisciplinary Sciences, Germany; https://www.mpinat.mpg.de/pardo
Prof. Dr. Ildiko Szabo, Pharmacological targeting of mitochondrial ion channels to selectively induce apoptosis in cancer cells, University of Padova, Italy; https://www.biologia.unipd.it/en/department/people/teacher-details/?tx_wfqbe_pi1%5Baccount%5D=ildiko-szabo
Prof. Dr. Annarosa Arcangeli, biophysical aspects of intracellular signalling by controlling cell growth and differentiation of tumour cells, University of Florence, Italy; https://biography.omicsonline.org/italy/university-of-firenze/annarosa-arcangeli-373700
Dr. Csaba Pal, New antibacterial compounds with limited resistance, BRC institute, Szeged, Hungary (ERC starting grant, ERC consolidator grant, ERC proof of concept grant); http://group.szbk.u-szeged.hu/sysbiol/pal-csaba-lab-member.html#csaba-pal
Prof. Dr. Bojana Žegura, Development of high-throughput genotoxicity test systems for rapid detection of genotoxic agents; National Institute of Biology; Environmental and genetic toxicology; http://www.nib.si/eng/index.php/research#example-2-tab-3
Prof. Dr. Maja Čemažar, Development and evaluation of new, innovative approaches in cancer treatment, preclinical and clinical research; Institute of Oncology Ljubljana, Department of Experimental Oncology; Slovenia; https://www.onko-i.si/eng/sectors/research_and_education/department_of_experimental_oncology
Prof. Dr. Zoltán Varga, Biological evaluation of voltage-gated proton, sodium and potassium channel inhibitors, University of Debrecen, Faculty of Medicine, Department of Biophysics and Cell Biology, Debrecen, Hungary; https://biophys.med.unideb.hu/en/dr-zoltan-varga
Dr. Martin Distel, Evaluation of anticancer activity in zebrafish xenograft models, St. Anna Kinderkrebsforschung, Children’s Cancer Research Institute, Innovative Cancer Models and ZANDR-Platform, Vienna, Austria; https://ccri.at/innovative-cancer-models-zandr/
Prof. Dr. Geert Bultynck, Development of new allosteric inhibitors of IP3 receptor channels, KU Leuven, Belgium; https://www.kuleuven.be/wieiswie/en/person/00019147
Dr. Krzesimir Ciura, Evaluation of physico-chemical properties of compounds, Faculty of Pharmacy, Medical University of Gdansk, Poland; https://ppm.gumed.edu.pl/search/author?ps=20&t=simple&showRel=false&lang=en&qp=&cid=65999
Dr. Zrinka Rajić, Development of Hsp90 inhibitors, Faculty of Pharmacy and Biochemistry; University of Zagreb, Croatia; https://www.pharma.unizg.hr/en/about-us/staff/zrinka-rajic,431.html